Cutler Group LP Vbi Vaccines Inc Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$0.66 - $1.81 $264 - $724	-400 Reduced 40.0%	600 $0
Q1 2022 Apr 14, 2022	SELL	$1.27 - $2.47 $5,842 - $11,362	-4,600 Reduced 82.14%	1,000 $0
Q4 2021 Jan 18, 2022	BUY	$2.21 - $3.22 $8,840 - $12,880	4,000 Added 250.0%	5,600 $0
Q3 2021 Oct 26, 2021	SELL	$2.8 - $3.72 $27,440 - $36,456	-9,800 Reduced 85.96%	1,600 $1,000
Q2 2021 Jul 19, 2021	BUY	$2.61 - $4.17 $13,572 - $21,684	5,200 Added 83.87%	11,400 $2,000
Q1 2021 Apr 26, 2021	SELL	$2.91 - $4.32 $13,095 - $19,440	-4,500 Reduced 42.06%	6,200 $2,000
Q4 2020 Jan 21, 2021	SELL	$2.15 - $3.5 $33,110 - $53,900	-15,400 Reduced 59.0%	10,700 $3,000
Q3 2020 Oct 27, 2020	BUY	$2.77 - $6.17 $22,437 - $49,977	8,100 Added 45.0%	26,100 $7,000
Q2 2020 Jul 22, 2020	SELL	$0.87 - $3.13 $3,654 - $13,146	-4,200 Reduced 18.92%	18,000 $9,000
Q1 2020 May 07, 2020	BUY	$0.73 - $1.91 $11,315 - $29,605	15,500 Added 231.34%	22,200 $5,000
Q4 2019 Feb 06, 2020	BUY	$0.48 - $1.38 $3,216 - $9,246	6,700 New	6,700 $3,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.